News

pharmahungary

 

Pharmahungary Group Press Release

EVEREST Project Aims to Revolutionise Biomedical Research with Extracellular Vesicles in 2025.

The project will bring together 21 institutions from 11 countries with a budget of €1.3 million to advance the study of extracellular vesicles (EVs).

EVs, small particles that act as messengers between cells, have the potential to transform early diagnosis and targeted treatments for diseases such as cancer and cardiovascular conditions.

Further details here.
2024. 11. 15.

pharmahungary

 

Pharmahungary Group Press Release

Péter Ferdinandy, MD, PhD, MBA, the Founder & CEO of Pharmahungary Group, has been recognized as a ‘Highly Cited Researcher’ for the sixth time in 2023.

Further details here.
2023. 12. 11.

pharmahungary

 

Pharmahungary Group Press Release

The Pharmahungary group, in cooperation with the Semmelweis University Institute of Pharmacology and Pharmacotherapy, is looking for a research project manager in the field of cardiovascular drug development.

Further details here.
2023. 04. 25.

Pharmahungary Group Press Release

Pharmahungary Group and Remembrane developed and validated a medium throughput in vitro screening platform for testing potential cardiocytoprotective drug candidates against ischemia/reperfusion injury in the presence of hypercholesterolemia/metabolic disease comorbidities.

Further information here

Meet In Italy for Life Sciences 2015

Date: September 29-October 2, 2015
Helyszín: Milano, Italy
The international event in life sciences to boost your business, partnering and networking opportunities
Application deadline: September 11, 2015

More info